Mangoceuticals, Inc.
MGRX
$2.49
-$0.08-3.11%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 5.49% | -27.43% | -40.53% | -98.68% | -361.06% |
| Total Depreciation and Amortization | 2,837.75% | -28.89% | 35.80% | 150.00% | 538.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.20% | 101.03% | 44.47% | 35.73% | 250.45% |
| Change in Net Operating Assets | 5,027.61% | 3,543.81% | 1,921.33% | 153,750.00% | -170.90% |
| Cash from Operations | 30.49% | 8.70% | -23.52% | -97.06% | -419.67% |
| Capital Expenditure | -- | 100.00% | 100.00% | 100.00% | 91.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 1,957.14% | 247.39% | 239.48% | 100.00% | 91.88% |
| Total Debt Issued | -- | -- | 187,400.00% | 250.00% | -- |
| Total Debt Repaid | -- | 100.00% | 100.00% | -567.33% | -567.33% |
| Issuance of Common Stock | -81.61% | -72.90% | -77.96% | -65.65% | 261.23% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -41.50% | -33.83% | -55.88% | -66.79% | 244.26% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,308.53% | -419.98% | -183.39% | -201.01% | -91.47% |